Rodman & Renshaw Starts Ascentage Pharma Group (AAPG) at Buy Jan 13, 2026 07:20AM
Ascentage Pharma presents four-year data on leukemia drug olverembatinib Dec 9, 2025 06:06AM
Ascentage Pharma reports phase III data for leukemia drug candidate Dec 9, 2025 06:06AM
Ascentage Pharma reports updated trial data for blood cancer drug Dec 9, 2025 06:06AM
Oppenheimer Starts Ascentage Pharma Group (AAPG) at Outperform Dec 4, 2025 06:03AM


Nov 24, 2025 07:34AM Truist Securities Starts Ascentage Pharma Group (AAPG) at Buy
Nov 10, 2025 06:08AM BTIG Starts Ascentage Pharma Group (AAPG) at Buy
Nov 5, 2025 03:40AM Piper Sandler Starts Ascentage Pharma Group (AAPG) at Overweight
Jul 14, 2025 10:36AM Ascentage Pharma prices $192.3 million share placement at HKD68.60
Jul 14, 2025 05:57AM Ascentage Pharma announces proposed share placement by CEO affiliate
Jul 10, 2025 09:31AM Ascentage Pharma gets China approval for cancer drug lisaftoclax
Apr 21, 2025 07:01AM Ascentage Pharma (AAPG) Announces Inclusion of Lisaftoclax and Olverembatinib in Chinese Society of Clinical Oncology (CSCO) 2025 Guidelines
Mar 27, 2025 02:08AM JPMorgan Starts Ascentage Pharma Group (AAPG) at Overweight
Feb 7, 2025 08:25AM Ascentage Pharma (AAPG) Announces Partial Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares
Jan 24, 2025 11:03AM Ascentage Pharma (AAPG) IPO opens flat at $17.25